Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway

Jun Ding; Chuang Qi; Jinmao Li; Chuying Huang; Jiayao Zhang; Yong Zhang; Yi Li; Bin Fan

doi:10.12659/MSM.929255

04 August 2021 : Animal Research

Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway

Jun Ding^1ABCDEFG*, Chuang Qi^2BCDEF, Jinmao Li^1BCDF, Chuying Huang^2BCD, Jiayao Zhang^1BCF, Yong Zhang^1BC, Yi Li^1BCF, Bin Fan^1CF

DOI: 10.12659/MSM.929255

Med Sci Monit 2021; 27:e929255

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Se-methylselenocysteine (MSC) treatments improved liver functions by modulating levels of (A) total bilirubin, (B) alkaline phosphatase, (C) γ-glutamyl transpeptidase, and (D) albumin in serum of rats in different groups. ## P<0.01 vs Normal control group. * P<0.05 and ** P<0.01 vs Model group.

Back to the Article

Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway

Your Privacy